George Eliot Hospital is taking part in a national project which could use genetic information to revolutionise the way cancer and rare diseases are treated.
As part of a West Midlands-wide group of 18 NHS Trusts, the hospital is signed up to the 100,000 Genomes Project .The initiative involves sequencing 100,000 human genomes – complete sets of people’s genes, plus all the DNA in between – that will enable scientists and doctors to understand more about specific conditions.
The 100,000 Genomes Project, announced by the Prime Minister in 2012, aims to transform diagnosis and treatment for patients with cancer and rare diseases. The target is to create a new genomic medicine service for the NHS, transforming the way people are cared for.
Patients with a rare disease, plus their families, and patients with cancer will be invited to take part. After DNA samples are collected, they are sent securely to be sequenced and analysed. Results sent back to the NHS for validation and clinical action.
George Eliot Hospital’s Medical Director, Dr Gordon Wood said: ”We are proud to be involved in such a pioneering national project that will benefit patients with cancer and rare diseases. Understanding the role of DNA in treating and predicting disease is an increasingly important area in medicine and I’m delighted that the George Eliot can contribute.”
Around 75,000 people will be involved nationally.